Consumer Insights
Uncover trends and behaviors shaping consumer choices today
Procurement Insights
Optimize your sourcing strategy with key market data
Industry Stats
Stay ahead with the latest trends and market analysis.
Report Overview
2023
Base Year
2017-2023
Historical Year
2024-2032
Forecast Year
Asia Pacific Stem Cell Assay Market Outlook
The global stem cell assay market size was valued at USD 6.4 billion in 2023, with Asia Pacific holding a significant market share. The market is driven by the rising emphasis on stem cell research. It is expected to grow at a CAGR of 13.18% during the forecast period of 2024-2032, with the values likely to attain USD 19.4 billion by 2032.
Key Takeaways
- In February 2023 , a study revealed that chronic diseases are highly prevalent in China among older adults, with the data reporting the national prevalence of any chronic disease to be 81.1% in people aged 60 and older. The growing chronic disease burden and aging population in the Asia Pacific region directly impact the market demand for stem cell assays.
- The rising investment in stem cell manufacturing facilities from both private and public sectors is expected to elevate the Asia Pacific stem cell assay market value. In May 2023 , StemCures announced an investment amounting to USD 54 million in setting up India’s largest stem cell manufacturing lab in Telangana.
- Several countries in the Asia Pacific region are actively engaged in clinical studies to evaluate the efficacy and safety of therapeutic stem cell products. This rapid expansion of stem cell therapy clinical trials is poised to augment the market share.
Asia Pacific Stem Cell Assay Market Analysis
Stem cell assays are widely utilized to assess the characteristics, behavior, and properties of stem cells. They enable the researchers to study various aspects of stem cell biology, such as proliferation, differentiation, and viability. Several countries in the Asia Pacific region are actively engaged in clinical studies to evaluate the efficacy and safety of stem cell therapies. This rapid expansion of clinical research directly impacts the demand for this laboratory technique to validate certain attributes of therapeutic stem cell products and thus, significantly contributes to the Asia Pacific stem cell assay market growth.
In Asia Pacific, the prevalence of chronic diseases like cancer, diabetes, and cardiovascular disorders is witnessing a sharp increase. In February 2023 , a study published in the Journal of the American Medical Directors Association revealed that chronic diseases are highly prevalent in China among older adults, with the data reporting the national prevalence of any chronic disease to be 81.1% in people aged 60 and older. The prevalence rate peaked at 80 to 84 years old, indicating about 87.2% of individuals affected by some chronic health condition. Since stem cell research has the potential to develop novel treatments, the demand for stem cell assays to evaluate drug properties is likely to rise with the growing chronic disease burden and aging population in the region.
One of the major Asia Pacific stem cell assay market trends is the rising investment in stem cell manufacturing facilities from both private as well as public sectors. In May 2023 , StemCures, a stem cell treatment provider based in the United States announced an investment amounting to USD 54 million in setting up India’s largest stem cell manufacturing lab in Telangana (a southern state). Leveraging the latest technology and expertise, the proposed lab aims to develop high-quality and affordable stem cell products for the treatment of various medical conditions. Such substantial investment in stem cell facilities to boost research efforts and stimulate innovation in the stem cell field is expected to elevate the market value.
The growing demand for regenerative medicine, including stem cell therapies, is also influencing the market dynamics. Further, the rise in strategic collaborations among academic institutions, research organizations, and pharmaceutical companies to translate stem cell research into clinical applications is bolstering the demand for stem assays, thereby supporting market growth.
Asia Pacific Stem Cell Assay Market Segmentation
The report offers a detailed analysis of the market based on the following segments:
| Market Breakup | Categories |
| Cell Type | Adult Stem Cells, Human Embryonic Stem Cells, Pluripotent |
| Type | Viability/Cytotoxicity Assays, Isolation & Purification Assays, Cell Identification Assays, Proliferation Assays, Differentiation Assays, Function Assays, Apoptosis Assays, Others |
| Product & Service | Flow Cytometers, Cell Imaging & Analysis Systems, Microelectrode Arrays, Automated Cell Counters, Kits |
| Treatment | Allogeneic Stem Cell Therapy, Autologous Stem Cell Therapy, Syngeneic Stem Cell Therapy |
| Application | Regenerative Medicine and Therapy Development, Drug Discovery and Development, Clinical Research, Others |
| End User | Biopharmaceutical and Biotechnology Companies, Academic and Research Institutes, Others |
| Countries | China, Japan, India, ASEAN, and Australia, Others |
Asia Pacific Stem Cell Assay Market: Competitor Landscape
The key features of the market report include patent analysis, funding and investment analysis, partnerships, and collaborations analysis by the leading key players. The major companies in the market are as follows:
- Thermo Fisher Scientific
- PerkinElmer
- Stemcell Technologies
- Merck
- Bio-Rad Laboratories
- Agilent Technologies
- Promega
- Bio-Techne
- Cell Biolabs
Kindly note that this only represents a partial list of companies, and the complete list has been provided in the report.
Key Highlights of the Report
| REPORT FEATURES | DETAILS |
| Base Year | 2023 |
| Historical Period | 2017-2023 |
| Forecast Period | 2024-2032 |
| Scope of the Report |
Historical and Forecast Trends, Industry Drivers and Constraints, Historical and Forecast Market Analysis by Segment:
|
| Breakup by Cell Type |
|
| Breakup by Type |
|
| Breakup by Product & Service |
|
| Breakup by Treatment |
|
| Breakup by Application |
|
| Breakup by End User |
|
| Breakup by Region |
|
| Market Dynamics |
|
| Supplier Landscape |
|
| Companies Covered |
|
Asia Pacfic Stem Cell Assay Market Report Snapshots
Asia Pacfic Stem Cell Assay Market Size
*While we strive to always give you current and accurate information, the numbers depicted on the website are indicative and may differ from the actual numbers in the main report. At Expert Market Research, we aim to bring you the latest insights and trends in the market. Using our analyses and forecasts, stakeholders can understand the market dynamics, navigate challenges, and capitalize on opportunities to make data-driven strategic decisions.*
Looking for specific insights?
Get in touch with us for a customized solution tailored to your unique requirements and save upto 35%!
Key Questions Answered in the Report
The Asia Pacific stem cell assay market is expected to be driven by the rising demand for the global market, which is anticipated to grow at a CAGR of 13.18% during the forecast period of 2024-2032 and is likely to reach a market value of USD 19.4 billion by 2032.
The rising emphasis on stem cell research and the increasing prevalence of chronic diseases are fuelling the demand for the market.
One of the significant trends in the market is the rising investment in stem cell manufacturing facilities from both private and public sectors. In May 2023 , StemCures announced an investment amounting to USD 54 million in setting up India’s largest stem cell manufacturing lab in Telangana.
The market breakup by cell type includes adult stem cells, human embryonic stem cells, and pluripotent.
By type, the market is divided into viability/cytotoxicity assays, isolation and purification assays, cell identification assays, proliferation assays, differentiation assays, function assays, and apoptosis assays, among others.
Based on the product and services, the market is segmented into flow cytometers, cell imaging & analysis systems, microelectrode arrays, automated cell counters, and kits.
Treatments available in the market include allogeneic stem cell therapy, autologous stem cell therapy, and syngeneic stem cell therapy.
Major application areas include regenerative medicine and therapy development, drug discovery and development, along with clinical research, among others.
End users of the market are biopharmaceutical and biotechnology companies, academic and research institutes, among others.
The market segmentation by countries includes China, Japan, India, ASEAN, and Australia, among others.
The key players in the market are Thermo Fisher Scientific, PerkinElmer, Stemcell Technologies, Merck, Bio-Rad Laboratories, Agilent Technologies, Promega, Bio-Techne, and Cell Biolabs.
Purchase Full Report
Datasheet
- Selected Sections, One User
- Printing Not Allowed
- Email Delivery in PDF
Free Limited CustomisationPost Sales Analyst Support50% Discount on Next Update
Single User License
One User
- All Sections, One User
- One Print Allowed
- Email Delivery in PDF
Free Limited CustomisationPost Sales Analyst Support50% Discount on Next Update
Five User License
Five Users
- All Sections, Five Users
- Five Prints Allowed
- Email Delivery in PDF
- Free Limited Customisation
- Post Sales Analyst Support
50% Discount on Next Update
Corporate License
Unlimited Users
- All Sections, Unlimited Users
- Unlimited Prints Allowed
- Email Delivery in PDF + Excel
- Free Limited Customisation
- Post Sales Analyst Support
- 50% Discount on Next Update
How To Order
Our step-by-step guide will help you select, purchase, and access your reports swiftly, ensuring you get the information that drives your decisions, right when you need it.
Select License Type
Choose the right license for your needs and access rights.
Click on ‘Buy Now’
Add the report to your cart with one click and proceed to register.
Select Mode of Payment
Choose a payment option for a secure checkout. You will be redirected accordingly.
Gain insights to stay ahead and seize opportunities.
Get insights & trends for a competitive edge.
Track prices with detailed trend reports.
Analyse trade data for supply chain insights.
Leverage cost reports for smart savings
Enhance supply chain with partnerships.
Connect For More Information
Our expert team of analysts will offer full support and resolve any queries regarding the report, before and after the purchase.
Our expert team of analysts will offer full support and resolve any queries regarding the report, before and after the purchase.
We employ meticulous research methods, blending advanced analytics and expert insights to deliver accurate, actionable industry intelligence, staying ahead of competitors.
Our skilled analysts offer unparalleled competitive advantage with detailed insights on current and emerging markets, ensuring your strategic edge.
We offer an in-depth yet simplified presentation of industry insights and analysis to meet your specific requirements effectively.
Subscribe to our Newsletter
By subscribing you agree to with our privacy policy and provide
consent to
receive
updates
from our company.
Our Offices
Australia
63 Fiona Drive, Tamworth, NSW
+61 448 06 17 27
India
C130 Sector 2 Noida, Uttar Pradesh 201301
+91-858-608-1494
Philippines
40th Floor, PBCom Tower, 6795 Ayala Avenue Cor V.A Rufino St. Makati City,1226.
+63 287899028, +63 967 048 3306
United Kingdom
6 Gardner Place, Becketts Close, Feltham TW14 0BX, Greater London
+44-753-713-2163
United States (Head Office)
30 North Gould Street, Sheridan, WY 82801
+1-415-325-5166
Vietnam
193/26/4 St.no.6, Ward Binh Hung Hoa, Binh Tan District, Ho Chi Minh City
+84865399124